MUCOMMUNE
Mucommune is a privately-held preclinical stage company launched based on the “muco-trapping” monoclonal antibodies (mAb) platform developed at Johns Hopkins University and University of North Carolina at Chapel Hill.
MUCOMMUNE
Industry:
Biotechnology Pharmaceutical
Founded:
2015-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.mucommune.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
36.53 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Google Apps For Business Google GStatic Google Static Content Google Cloud
Current Employees Featured
Founder
Investors List
One North Carolina Small Business Program
One North Carolina Small Business Program investment in Grant - Mucommune
Official Site Inspections
http://www.mucommune.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Mucommune"
Home | Mucommune
Mucommune is a professional R&D organization with a strong track record in advancing early-stage academic discoveries and inventions into IND-enabling preclinical studies and clinical …See details»
About Us - Mucommune
Mucommune is a privately-held R&D company. It was originally launched in 2016 based on the 'muco-trapping' monoclonal antibodies (mAb) platform developed at John Hopkins University …See details»
Technology & Platform | Mucommune
At the heart of Mucommune are world-class expertise in bioengineering, immunology, drug delivery, and mucosal biology that enables it to effectively advance diverse technologies into …See details»
Mucommune - Crunchbase Company Profile & Funding
Mucommune is a privately-held preclinical stage company launched based on the “muco-trapping” monoclonal antibodies (mAb) platform. View contacts for Mucommune to access new leads …See details»
Mucommune Company Profile 2024: Valuation, Funding
Developer of a monoclonal antibodies (mAb) platform intended to focus on the engineering of antibodies and biologics.See details»
Mucommune, LLC - BIO International Convention | BIO
Jun 6, 2023 · Mucommune is a privately-held startup focused on women's reproductive health. The lead product focuses on enabling non-hormonal contraception, in the form of anti-sperm …See details»
Mucommune LLC | North Carolina Biotech Center
Mucommune is developing a platform using monoclonal antibodies and mucus to reinforce the mucus barrier for female reproductive health. Company Location https://www.mucommune.comSee details»
Mucommune - LinkedIn
Advancing Innovations to Promote Female Reproductive Health | First in-class platform for harnessing the synergy between antibodies and mucus to reinforce the mucus barrier for …See details»
Sam Lai - Founder & Interim CEO at Mucommune - The Org
Dr. Sam Lai is a pharmacoengineering & molecular pharmaceutics professor at the University of North Carolina at Chapel Hill, and the founder of Mucommune. Lai's research interests include …See details»
Mucommune Is Newest Resident of UNC Eshelman Institute …
Mucommune, LLC, is the fourth company spun out of the research enterprise at the UNC Eshelman School of Pharmacy to take up residence in the Eshelman Institute for Innovation …See details»
UNC researchers developing mucus-trapping antibody tech to …
Jan 29, 2020 · Mucommune’s muco-trapping antibody technology enables antibodies – proteins in the immune system that fight intruders in the body – to immobilize viral and bacterial …See details»
Mucommune Receives Over $3M to Advance Muco-Trapping …
Mucommune LLC has been awarded over $3 million in five separate federal grants over the past several months to advance its muco-trapping antibody technology. The company was …See details»
Mucommune - Funding, Financials, Valuation & Investors
Mucommune is a privately-held preclinical stage company launched based on the “muco-trapping” monoclonal antibodies (mAb) platform.See details»
Careers | Mucommune
We are always seeking highly motivated individuals who strive to make a difference through science to join our team. The Mucommune team has broad in-house expertise in female …See details»
Mucommune - Tech Stack, Apps, Patents & Trademarks
Mucommune is a privately-held preclinical stage company launched based on the “muco-trapping” monoclonal antibodies (mAb) platform.See details»
Mucommune - VentureRadar
Mucommune is focused on harnessing IgG-mucin interactions to reinforce mucosal health against microbial infections. ... Find out more about Mucommune, Biotech and Biotechnology.See details»
Engineering monoclonal antibody-based contraception and …
Aug 4, 2020 · We are producing new antibody-based multipurpose prevention technology products to address these problems and fill an unmet need in female reproductive health.See details»
Publications - Mucommune
Contraceptive mAbs Shrestha B, Schaefer A, Chavez E, Kopp AJ, Jacobs TM, Moench TR, Lai SK. (2020) Engineering tetravalent IgGs with enhanced agglutination potencies for trapping …See details»
Delivery of pathogen-trapping antibodies for vaginal protection
Feb 10, 2016 · By enabling enhanced mAb function in mucus secretions, we expect Mucommune will help pave the way for improved, molecularly-targeted therapies and prophylaxis against a …See details»
Pipeline | Mucommune
MM008, Non-hormonal contraceptive IVR/Tablet. MM009, Bacterial vaginosis. PolyonSee details»